Login
Navigate Fool.com
Will MRK beat
the market?

Merck & Co., Inc.

NYSE: MRK

Community Rating: 3 Stars: Appealing

56.47 0.21 (0.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.45
Previous Close $56.26
Daily Range $56.27 - $57.00
52-Week Range $44.60 - $58.14
Market Cap $166.1B
P/E Ratio 38.42
Dividend (Yield) $1.76 (3.1%)
Ex-Dividend Date
Dividend Pay Date
03/13/14
04/07/14
Volume 11,263,810
Average Daily Volume 11,414,212
Current FY EPS $3.46

How do you think MRK
will perform against the market?

Top MRK Bull/Bear Pitches

 

alcear (< 20)
Submitted April 29, 2011

rotation into healthcare

0 Replies Reply Report this Post
 

nitraMcoD (3.53)
Submitted August 25, 2006

There are fundamental shifts occurring in the industry that will eat away at the efficiencies MRK currently enjoys. While their response to these shifts will be correct, their size will slow down thei … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

3 Reasons the Market Is Down on Gilead Sciences

Gilead Sciences's competition from AbbVie and Merck is just one of the reasons.

Johnson & Johnson's 3 Major Strengths

What are the three key reasons why J&J could be a top performer in the future?

Roche Reaffirms Full Year Outlook But Suffers From Currency Movements

If This Biotech Drops Much Further I'm Going to Buy It!

This biotech behemoth dipped by more than 20% recently despite a growth rate that could easily equal 25% over the next five years. Needless to say, if it drops any further I'm going to buy it!

Will Merck & Co. Inc Unseat Biotech's Hottest Drug?

Gilead Sciences' oral hepatitis C drug Sovaldi has taken the market by storm, but Merck's looking to fight back in the race to capture this lucrative niche.

Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides

Is the plummeting valuation justified?

2 Reasons Why Merck & Co. Is Crushing the Dow

Merck is up double digits this year and outperforming the major indexes. Why?

Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer?

This Texas-based biotech reported positive proof-of-concept results earlier this week and could be set to upend a number of big pharmaceutical companies if its experimental drug continues to deliver.

How Much Has Merck Shaken Up the Hepatitis C Race?

Recent data presentations at the EASL conference highlight the emerging competition in hepatitis C.

Does Pfizer Offer Good Value?

With a recent P/E ratio in single digits, Pfizer may be the last value play in the pharmaceutical industry.

See More MRK News...

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks